Stay Up to Date
Breaking News,
Updates, & More
Click Here to
Subscribe

Patricia Stewart

Authored Items
Explosion of New Regimens for Multiple Myeloma: Selecting the Right Option for the Right Patient
Patricia Stewart
TON - December 2020, Vol 13, No 6 in NCCN
Aggressive Approach to High-Risk Smoldering Myeloma Gains Consensus
Patricia Stewart
TON - December 2020, Vol 13, No 6 in NCCN
CAR T-Cell Therapy May Not Be Needed for Select Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Patricia Stewart
TON - December 2020, Vol 13, No 6 in NCCN
Sotorasib Demonstrates Promising Antitumor Activity in Patients with Advanced NSCLC
Patricia Stewart
TON - December 2020, Vol 13, No 6 in Emerging Therapies
Xevinapant plus CRT Improves Survival in Patients with Locally Advanced HNSCC
Patricia Stewart
TON - December 2020, Vol 13, No 6 in Emerging Therapies
Personalized Vaccine plus Atezolizumab Shows Promising Clinical Activity in Advanced Cancer
Patricia Stewart
TOP - November 2020 Vol 13, No 6 in AACR Highlights
Olaparib Significantly Improves Survival in Men with Metastatic Prostate Cancer and BRCA Mutations
Patricia Stewart
TOP - November 2020 Vol 13, No 6 in ESMO 2020
“Practice-Changing” Results Seen with Adjuvant Abemaciclib plus Endocrine Therapy in HR-Positive, HER2-Negative Breast Cancer
Patricia Stewart
TOP - November 2020 Vol 13, No 6 in ESMO 2020
Cabozantinib plus Nivolumab Offers New First-Line Treatment Option for Patients with Advanced Renal-Cell Carcinoma
Patricia Stewart
TOP - November 2020 Vol 13, No 6 in ESMO 2020
Real-World Analysis Shows Survival Benefit with Adjuvant Immunotherapy in Stage III Melanoma
Patricia Stewart
TOP - November 2020 Vol 13, No 6 in AACR Highlights
COVID-19: Facing the Challenges Ahead
Patricia Stewart
TOP - November 2020 Vol 13, No 6 in AACR Highlights, COVID-19
COVID-19 Increases Overall Risk for Death in Patients with Cancer
Patricia Stewart
TOP - November 2020 Vol 13, No 6 in AACR Highlights, COVID-19
Immune Checkpoint Inhibitors Do Not Increase Mortality in Patients with Cancer and COVID-19
Patricia Stewart
TOP - November 2020 Vol 13, No 6 in AACR Highlights, COVID-19
Relugolix May Become New Standard of Care for Advanced Prostate Cancer
Patricia Stewart
TOP - November 2020 Vol 13, No 6 in Prostate Cancer
Surgery and Radiation Do Not Extend Survival in Newly Diagnosed Stage IV Breast Cancer
Patricia Stewart
TOP - November 2020 Vol 13, No 6 in Breast Cancer
Durvalumab plus Chemotherapy Improves Overall Survival in Extensive-Stage Small-Cell Lung Cancer
Patricia Stewart
TOP - September 2020 Vol 13, No 5 in Lung Cancer
Avelumab as Maintenance Prolongs Survival in Advanced Bladder Cancer
Patricia Stewart
TOP - September 2020 Vol 13, No 5 in Bladder Cancer
Adjuvant Atezolizumab Does Not Show Disease-Free Survival Benefit in High-Risk Bladder Cancer
Patricia Stewart
TOP - September 2020 Vol 13, No 5 in Bladder Cancer
Last modified: August 17, 2020